JP2023533153A5 - - Google Patents
Info
- Publication number
- JP2023533153A5 JP2023533153A5 JP2022574424A JP2022574424A JP2023533153A5 JP 2023533153 A5 JP2023533153 A5 JP 2023533153A5 JP 2022574424 A JP2022574424 A JP 2022574424A JP 2022574424 A JP2022574424 A JP 2022574424A JP 2023533153 A5 JP2023533153 A5 JP 2023533153A5
- Authority
- JP
- Japan
- Prior art keywords
- tds
- nucleoside
- modified
- pharmaceutical composition
- modified oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063044345P | 2020-06-25 | 2020-06-25 | |
| US63/044,345 | 2020-06-25 | ||
| US202063079438P | 2020-09-16 | 2020-09-16 | |
| US63/079,438 | 2020-09-16 | ||
| PCT/US2021/039049 WO2021263082A2 (en) | 2020-06-25 | 2021-06-25 | Compounds and methods for reducing kcnt1 expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533153A JP2023533153A (ja) | 2023-08-02 |
| JP2023533153A5 true JP2023533153A5 (cg-RX-API-DMAC7.html) | 2024-07-02 |
Family
ID=79281885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574424A Pending JP2023533153A (ja) | 2020-06-25 | 2021-06-25 | Ｋｃｎｔ１の発現を低減するための化合物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240229042A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4171576A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023533153A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115701998A (cg-RX-API-DMAC7.html) |
| UY (1) | UY39297A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021263082A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025117662A1 (en) * | 2023-11-29 | 2025-06-05 | Actio Biosciences, Inc. | Heterocyclic compounds useful as kcnt1 inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020048787A1 (en) * | 2000-06-14 | 2002-04-25 | Ming-Hui Wei | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| WO2005083127A2 (en) * | 2004-02-27 | 2005-09-09 | Applera Corporation | Genetic polymorphisms associated with stroke, methods of detection and uses thereof |
| US20200129538A1 (en) * | 2017-06-13 | 2020-04-30 | The Florey Institute Of Neuroscience And Mental Health | Compositions and methods for treating conditions associated with gain-of-function mutations in kcnt1 |
| AU2019406186A1 (en) * | 2018-12-20 | 2021-07-15 | Praxis Precision Medicines, Inc. | Compositions and methods for the treatment of KCNT1 related disorders |
-
2021
- 2021-06-25 JP JP2022574424A patent/JP2023533153A/ja active Pending
- 2021-06-25 US US18/001,853 patent/US20240229042A1/en active Pending
- 2021-06-25 WO PCT/US2021/039049 patent/WO2021263082A2/en not_active Ceased
- 2021-06-25 EP EP21828398.4A patent/EP4171576A4/en active Pending
- 2021-06-25 CN CN202180045166.3A patent/CN115701998A/zh active Pending
- 2021-06-25 UY UY0001039297A patent/UY39297A/es not_active Application Discontinuation